Stock TELA TELA BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company TELA Bio, Inc.

Equities

TELA

US8723811084

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
4.45 USD +1.37% Intraday chart for TELA Bio, Inc. -6.32% -32.78%
Apr. 15 TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR CI
Mar. 22 Piper Sandler Adjusts Price Target on TELA Bio to $12 From $15, Maintains Overweight Rating MT

Business Summary

TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, and OviTex LPR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.

Number of employees: 227

Sales per Business

USD in Million2022Weight2023Weight Delta
Soft-tissue Reconstruction Solutions
100.0 %
41 100.0 % 58 100.0 % +41.13%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
41 100.0 % 58 100.0 % +41.13%

Managers

Managers TitleAgeSince
Antony Koblish FOU
 Founder 58 12-04-16
Roberto Cuca DFI
 Director of Finance/CFO 57 21-09-26
Marissa Conrad CTO
 Chief Tech/Sci/R&D Officer - 21-05-23
Paul Talmo CTO
 Chief Tech/Sci/R&D Officer 57 14-01-31
Gregory Peter Chodaczek IRC
 Investor Relations Contact - -
D. Taylor Ocasio LAW
 General Counsel - 22-04-17
Megan Smeykal AUD
 Comptroller/Controller/Auditor 48 19-11-30
Bruce Freedman PRN
 Corporate Officer/Principal - 20-12-31
Peter Murphy PRN
 Corporate Officer/Principal 52 20-01-28
Michael Leonard PRN
 Corporate Officer/Principal - 18-03-31

Members of the board

Members of the board TitleAgeSince
Lisa Colleran BRD
 Director/Board Member 66 20-04-19
Douglas Evans CHM
 Chairman 59 20-04-19
Antony Koblish FOU
 Founder 58 12-04-16
Vince Burgess BRD
 Director/Board Member 59 14-05-31
Federica O’Brien BRD
 Director/Board Member 66 19-11-12
Kurt Azarbarzin BRD
 Director/Board Member 61 18-11-05

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 24,653,939 22,995,548 ( 93.27 %) 0 93.27 %

Shareholders

NameEquities%Valuation
Essex Woodlands Management, Inc.
16.68 %
4,110,709 16.68 % 23 M $
OrbiMed Advisors Private Equity
11.50 %
2,835,542 11.50 % 16 M $
First Light Asset Management LLC
10.36 %
2,554,641 10.36 % 14 M $
AIGH Capital Management LLC
5.590 %
1,377,945 5.590 % 8 M $
Nantahala Capital Management LLC
4.454 %
1,097,866 4.454 % 6 M $
BlackRock Advisors LLC
4.210 %
1,037,724 4.210 % 6 M $
Vanguard Fiduciary Trust Co.
4.052 %
998,853 4.052 % 6 M $
Pentwater Capital Management LP
4.016 %
990,000 4.016 % 6 M $
SilverArc Capital Management LLC
3.226 %
795,080 3.226 % 5 M $
Federated Global Investment Management Corp.
2.890 %
712,300 2.890 % 4 M $

Company contact information

TELA Bio, Inc.

1 Great Valley Parkway Suite 24

19355, Malvern

+

http://www.telabio.com
address TELA Bio, Inc.(TELA)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Other Medical Equipment, Supplies & Distribution

Ratings for TELA Bio, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
4.45 USD
Average target price
14.6 USD
Spread / Average Target
+228.09%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
TELA BIO, INC. Stock TELA Bio, Inc.
-32.78% 110M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. TELA Stock
  4. Company TELA Bio, Inc.